Cargando…
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes
RELEVANCE: Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer (OC). However, its anticancer mechanism remained to be further studied at the molecular levels. Ivermectin-related molecule-panel changes will serve a use...
Autores principales: | Li, Na, Zhan, Xianquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/ https://www.ncbi.nlm.nih.gov/pubmed/32549918 http://dx.doi.org/10.1007/s13167-020-00209-y |
Ejemplares similares
-
Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
por: Li, Na, et al.
Publicado: (2019) -
Datasets exploring putative lncRNA-miRNA-mRNA axes in breast cancer cell lines
por: Wasson, Marie-Claire D, et al.
Publicado: (2021) -
Construction of a disease‐specific lncRNA‐miRNA‐mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2020) -
Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression
por: Guo, Qiuyan, et al.
Publicado: (2015) -
Analysis of mRNA‑lncRNA and mRNA‑lncRNA-pathway co‑expression networks based on WGCNA in developing pediatric sepsis
por: Zhang, Xiaojuan, et al.
Publicado: (2021)